Brief: Dyadic Announces Agreement With Janssen For Manufacture Of Therapeutic Protein Candidates Using Its C1 Platform

Dyadic International

17/12/2021 13:47

Dec 17 (Reuters) - Dyadic International Inc  DYAI.O :
    * DYADIC ANNOUNCES RESEARCH, LICENSE AND COLLABORATION
AGREEMENT
WITH JANSSEN FOR MANUFACTURE OF THERAPEUTIC PROTEIN CANDIDATES
USING ITS C1 PLATFORM
    * DYADIC INTERNATIONAL INC- JANSSEN WILL PAY DYADIC AN
UPFRONT
PAYMENT OF $500,000 FOR NON-EXCLUSIVE RIGHTS TO UTILIZE C1
PLATFORM
    * DYADIC INTERNATIONAL INC- JANSSEN WILL PROVIDE RESEARCH
AND
DEVELOPMENT FUNDING UP TO EUR 1.6 MILLION TO DEVELOP AND ASSESS
C1 PRODUCTION CELL LINES FOR ITS PRODUCT CANDIDATES
    * DYADIC INTERNATIONAL INC- JANSSEN HAS OPTION TO PAY A
MID-SEVEN
FIGURE PAYMENT FOR AN EXCLUSIVE LICENSE FROM DYADIC TO USE C1
PLATFORM
    * DYADIC INTERNATIONAL INC- UPON SUCCESSFUL COMPLETION OF
TECHNOLOGY TRANSFER, DYADIC IS ELIGIBLE TO RECEIVE A MILESTONE
PAYMENT IN LOW SEVEN FIGURES

Source text for Eikon:  ID:nGNE2ySQND 
Further company coverage:  DYAI.O 

 ((Reuters.Briefs@thomsonreuters.com;))